Anticoagulation

Journal of Neurosurgery

Volumn 118, Issue 2, 2013, Pages 483-484

  Kuo, Ruth S ^a   Freeman, Wililiam D ^a   Tawk, Rabih G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; DABIGATRAN; HEMOSTATIC AGENT; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

AGED; ANTICOAGULATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DISORIENTATION; GLASGOW COMA SCALE; HEADACHE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SUBDURAL HEMATOMA; THROMBIN TIME; THROMBOCYTE TRANSFUSION; TRAUMATIC BRAIN INJURY;

BENZIMIDAZOLES; BETA-ALANINE; BRAIN HEMORRHAGE, TRAUMATIC; BRAIN INJURIES; HUMANS; MALE; THROMBIN;

EID: 84873697404     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.7.JNS12650     Document Type: Letter

References (5)

1. Crowther MA, Warkentin TE: Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents. J Thromb Haemost 7 Suppl 1:107-110, 2009.
2. Eerenburg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M: Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebocontrolled, crossover study in healthy subjects. Circulation 124:1573-1579, 2011.
3. Garber ST, Sivakumar W, Schmidt RH: Neurosurgical complications of direct thrombin inhibitors-catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran. Case report. J Neurosurg 116:1093-1096, 2012.
4. van Ryn J, Stangier J, Haertter S, Leisenfeld KH, Wienen W, Feuring M, et al: Dabigatran etexilate- A novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 103:1116-1127, 2010.
5. Watanabe M, Siddiqui FM, Qureshi AI: Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment. Neurocrit Care 16:203-209, 2012.